Endocyte Reports Third Quarter Financial Results
Nov 06, 2017 21:01 pm UTC| Business
– Plans to Initiate Phase 3 Registration for 177Lu-PSMA-617 Accelerated by Radiomedix Agreement to Transfer Active U.S. Investigational New Drug Application (IND) to Endocyte – – The University of Sydney...
Gippsland Health Alliance selects Allscripts EMR
Nov 06, 2017 21:01 pm UTC| Business
MELBOURNE, Australia, Nov. 06, 2017 -- As a result of a competitive tender, Gippsland Health Alliance has selected Allscripts (NASDAQ:MDRX) to deliver an Electronic Medical Record (EMR) solution to the Gippsland Health...
Spero Therapeutics Announces Closing of Initial Public Offering
Nov 06, 2017 21:01 pm UTC| Business
CAMBRIDGE, Mass., Nov. 06, 2017 -- Spero Therapeutics, Inc., a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant...
Federated National Holding Company Reports Third Quarter 2017 Results
Nov 06, 2017 21:00 pm UTC| Business
SUNRISE, Fla., Nov. 06, 2017 -- Federated National Holding Company (the “Company”) (Nasdaq:FNHC) today reported results for the three and nine months ended September 30, 2017. Q3 2017 highlights (as measured against...
Nov 06, 2017 21:00 pm UTC| Business
SAN DIEGO, Nov. 06, 2017 -- Kratos Defense Security Solutions, Inc. (“Kratos”) (Nasdaq:KTOS), announced today that it intends to offer, subject to market and other customary conditions, $300 million aggregate principal...
Coherus BioSciences Reports Third Quarter 2017 Operating and Financial Results
Nov 06, 2017 21:00 pm UTC| Business
REDWOOD CITY, Calif., Nov. 06, 2017 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reported financial results and reviewed corporate events for the third quarter ended September 30, 2017. Corporate Highlights for...
Gevo Reports 3rd Quarter 2017 Financial Results
Nov 06, 2017 21:00 pm UTC| Business
- Gevo to Host Conference Call Today at 4:30 p.m. EST/2:30 MST - Reports net loss per share of ($0.25) for the quarter Reports non-GAAP Adjusted Net Loss Per Share1 of ($0.36) for the quarter Ended the quarter with...
Why Africa’s young scientists should help check the quality of climate change research